or Try an Advanced Search...

    ETF Components for TDI - Touchstone Dynamic International ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVO B 2.52 3.93
    NVS A 1.26 2.19

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Anti Diabetic Drugs Antibiotics Biopharmaceutical Biotechnology Blood Test Contact Lens Contact Lenses Diabetes Diabetes Care Diagnostic Products Disposable Product Disposable Products Drugs Endocrine System Eye Eye Care Eye Care Products Eyewear
    Industries: Biotechnology Drug Manufacturers - Major

    Recent News for Touchstone Dynamic International ETF & its Holdings

    Date Stock Title
    Jul 5 NVO Study links GLP-1 drugs, metformin to lower risk of certain cancers
    Jul 5 NVO Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
    Jul 5 NVS Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
    Jul 5 NVO Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
    Jul 5 NVO Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector
    Jul 5 NVS What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
    Jul 5 NVO Is It Too Late to Buy Novo Nordisk Stock?
    Jul 5 NVO Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
    Jul 4 NVO Novo Nordisk: Buy On Dips
    Jul 4 NVO NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
    Jul 3 NVO S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 NVO Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
    Jul 3 NVO Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
    Jul 3 NVO Weight-loss drugs linked to rare vision loss: Harvard study
    Jul 3 NVO Update: Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
    Jul 3 NVO Novo Nordisk’s Ozempic, Wegovy linked to eye disorder in small study
    Jul 3 NVO Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
    Jul 3 NVO Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
    Jul 3 NVO Should You Hold Novo Nordisk A/S (NVO) for the Long Term?
    Jul 2 NVO Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices
    TDI provides broad exposure to the global equity markets outside the US. The fund may include common and preferred stocks, depositary receipts, REITs, as well as other exchange-traded funds. To construct the portfolio, the funds sub-adviser employs the Dynamic Alpha Stock Selection Model, a proprietary quantitative model that seeks to construct a risk-controlled, forward-looking portfolio that adapts to changing market conditions. The model estimates returns based on each securitys risk characteristics through a three-step process that utilizes fundamental data and statistical tools. An optimization process is then used to identify the portfolio of around 100-140 securities with the highest expected return for an acceptable level of risk. The fund rebalances periodically. On December 11, 2023, TDI converted from a mutual fund to an actively managed ETF with $62 million in assets.
    Exchange Traded Fund Real Estate Investment Trust Quantitative Analysis
    Back to the Main TDI Page...